S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
MarketBeat Week in Review – 12/4 - 12/8
New CBOE “special perk” helps traders target income every weekend (Ad)
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
Indiana secretary of state appeals ruling for US Senate candidate seeking GOP nod
New CBOE “special perk” helps traders target income every weekend (Ad)
What is carbon capture and why does it keep coming up at COP28?
Dozens of animals taken from Virginia roadside zoo as part of investigation
New CBOE “special perk” helps traders target income every weekend (Ad)
Polish truck drivers are blocking the border with Ukraine. It's hurting on the battlefield
Peek inside Joe Biden's campaign fundraisers, where big money mingles with old jokes in swanky homes

Merit Medical Systems Stock Price, News & Analysis (NASDAQ:MMSI)

$69.82
+0.21 (+0.30%)
(As of 12/8/2023 ET)
Compare
Today's Range
$69.43
$70.09
50-Day Range
$62.92
$73.94
52-Week Range
$62.58
$85.62
Volume
646,479 shs
Average Volume
519,893 shs
Market Capitalization
$4.03 billion
P/E Ratio
40.36
Dividend Yield
N/A
Price Target
$85.50

Merit Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
22.5% Upside
$85.50 Price Target
Short Interest
Healthy
1.57% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
0.78mentions of Merit Medical Systems in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.46%
From $2.96 to $3.24 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

155th out of 941 stocks

Surgical & Medical Instruments Industry

24th out of 94 stocks


MMSI stock logo

About Merit Medical Systems Stock (NASDAQ:MMSI)

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

MMSI Stock Price History

MMSI Stock News Headlines

Merit Medical Systems Hold Rating Amid New Convertible Notes Issuance
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Merit Medical Caught Up In The Med-Tech Downswing
Q3 2023 Merit Medical Systems Inc Earnings Call
Analyst Expectations for Merit Medical Systems's Future
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/26/2023
Today
12/09/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/28/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,846
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$85.50
High Stock Price Target
$96.00
Low Stock Price Target
$70.00
Potential Upside/Downside
+22.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$74.52 million
Pretax Margin
9.03%

Debt

Sales & Book Value

Annual Sales
$1.15 billion
Cash Flow
$4.38 per share
Book Value
$20.11 per share

Miscellaneous

Free Float
55,613,000
Market Cap
$4.03 billion
Optionable
Optionable
Beta
0.90

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report














MMSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price target for 2024?

5 Wall Street research analysts have issued twelve-month target prices for Merit Medical Systems' stock. Their MMSI share price targets range from $70.00 to $96.00. On average, they expect the company's stock price to reach $85.50 in the next twelve months. This suggests a possible upside of 22.5% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How have MMSI shares performed in 2023?

Merit Medical Systems' stock was trading at $70.62 at the start of the year. Since then, MMSI stock has decreased by 1.1% and is now trading at $69.82.
View the best growth stocks for 2023 here
.

When is Merit Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our MMSI earnings forecast
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) announced its earnings results on Thursday, October, 26th. The medical instruments supplier reported $0.75 earnings per share for the quarter, beating analysts' consensus estimates of $0.65 by $0.10. The medical instruments supplier had revenue of $315.23 million for the quarter, compared to analysts' expectations of $306.25 million. Merit Medical Systems had a net margin of 8.17% and a trailing twelve-month return on equity of 14.71%.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems updated its FY23 earnings guidance on Thursday, October, 26th. The company provided earnings per share guidance of $2.93-2.99 for the period, compared to the consensus estimate of $2.88. The company issued revenue guidance of $1.242-1.251 billion, compared to the consensus revenue estimate of $1.24 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by many different retail and institutional investors. Top institutional investors include William Blair Investment Management LLC (6.75%), Conestoga Capital Advisors LLC (3.71%), Fuller & Thaler Asset Management Inc. (2.41%), Loomis Sayles & Co. L P (1.79%), Morgan Stanley (1.59%) and Invesco Ltd. (1.30%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, F Ann Millner, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Michel James Voigt, Neil Peterson, Raul Jr Parra and Ronald Frost.
View institutional ownership trends
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Merit Medical Systems have any subsidiaries?
The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More
This page (NASDAQ:MMSI) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -